CAS: 1163719-91-2
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | CCT241161 REF: 54-BUP07645CAS: 1163719-91-2 | ≥98% | 1.046,00 €~4.337,00 € | Lun 28 Apr 25 |
 | CCT241161 REF: TM-T9638CAS: 1163719-91-2 | 100% - 98.48% | 137,00 €~2.593,00 € | Mer 30 Apr 25 |
 | N-[4-[(3,4-dihydro-3-oxopyrido[2,3-b]pyrazin-8-yl)oxy]-2-(methylthio)phenyl]-N'-[3-(1,1-dimethylethyl)-1-phenyl-1H-pyrazol-5-yl]-ure a REF: 3D-NWB71991CAS: 1163719-91-2 | Min. 95% | - - - | Prodotto fuori produzione |
Ref: 54-BUP07645
| 1g | 4.337,00 € | ||
| 25mg | 1.046,00 € | ||
| 50mg | 1.270,00 € | ||
| 100mg | 1.750,00 € | ||
| 500mg | 3.512,00 € |
Consegna stimata in Stati Uniti, il Lunedì 28 Aprile 2025
CCT241161
CAS:1163719-91-2
CCT241161: oral pan-RAF inhibitor; IC50s: LCK (3 nM), CRAF (6), SRC (10), V600E-BRAF (15), BRAF …
Formula:
C28H27N7O3S
Purezza:
100% - 98.48%
Colore e forma:
Solid
Peso molecolare:
541.62
Ref: TM-T9638
| 1mg | 137,00 € | ||
| 5mg | 325,00 € | ||
| 10mg | 465,00 € | ||
| 25mg | 712,00 € | ||
| 50mg | 938,00 € | ||
| 100mg | 1.293,00 € | ||
| 500mg | 2.593,00 € |
Consegna stimata in Stati Uniti, il Mercoledì 30 Aprile 2025
![N-[4-[(3,4-dihydro-3-oxopyrido[2,3-b]pyrazin-8-yl)oxy]-2-(methylthio)phenyl]-N'-[3-(1,1-dimethylet…](https://static.cymitquimica.com/products/3D/thumb/NWB71991.jpg)
N-[4-[(3,4-dihydro-3-oxopyrido[2,3-b]pyrazin-8-yl)oxy]-2-(methylthio)phenyl]-N'-[3-(1,1-dimethylethyl)-1-phenyl-1H-pyrazol-5-yl]-ure a
CAS:1163719-91-2
Please enquire for more information about N-[4-[(3,4-dihydro-3-oxopyrido[2,3-b]pyrazin-8-yl)oxy]-2-(methylthio)phenyl]-N'-[3-(1,1-dimethylethyl)-1-phenyl-1H-pyrazol-5-yl]-ure a including the price, delivery time and more …
Formula:
C28H27N7O3S
Purezza:
Min. 95%
Peso molecolare:
541.6 g/mol
Ref: 3D-NWB71991
| 5mg | Fuori produzione | Richiedi informazioni | |
| 10mg | Fuori produzione | Richiedi informazioni | |
| 25mg | Fuori produzione | Richiedi informazioni | |
| 50mg | Fuori produzione | Richiedi informazioni |
